Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
EGTX.ST - Egetis Therapeutics AB (publ)
Q1 2025 Egetis Therapeutics AB (publ) Earnings Call
Apr 30, 2025 / 08:00AM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good Good morning and a warm welcome to GTI's quarter 1 results call planned for the coming 30 minutes. For those I haven't had the privilege to meet before, I'm Nicholas Westerho. I'm the CEO of the company.
With me today, I also have Yilmas Masheed, Chief Financial Officer, Henry Kruk, our head of commercial operations, and Carl Horde, head of investor relations.
Let's turn our attention to the topics covered today, but first, let me begin by saying that I'm incredibly proud of the full approval of MCA in the European Union on 13 February, which represents the single most important milestone in GTA's history and also marks a major step forward in building a sustainable, rare disease company. We
Trustpilot
